Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Torguson

Showing results (151-160 of 378) with videos related to

Pageof 38
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 7, 2006
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Rebecca Torguson, et al.
The American Journal of Cardiology|July 15, 2011
Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivityMichael A Gaglia, Rebecca Torguson, Rajbabu Pakala, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2013
The state of the excimer laser for coronary intervention in the drug-eluting stent eraSalem Badr, Itsik Ben-Dor, Danny Dvir, et al.
The American Journal of Cardiology|February 19, 2013
Prevalence and effect of myocardial injury after transcatheter aortic valve replacementIsrael M Barbash, Danny Dvir, Itsik Ben-Dor, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 17, 2014
Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary interventionSa'ar Minha, Joshua P Loh, Lowell F Satler, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2014
Outcome comparison of African-American and Caucasian patients with severe aortic stenosis subjected to transcatheter aortic valve replacement: a single-center experienceSa'ar Minha, Israel M Barbash, Marco A Magalhaes, et al.
The American Journal of Cardiology|July 6, 2012
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial)Ron Waksman, Magdi Ghali, Randy Goodroe, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 22, 2016
Promus Premier versus Xience V and Taxus Liberte in contemporary United States practice (REWARDS premier registry)Michael A Gaglia, Randy Goodroe, Greg Mishkel, et al.
The American Journal of Cardiology|December 6, 2006
Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trialsMichael J Lipinski, Thibault Lhermusier, Ricardo O Escarcega, et al.
Pageof 38

Showing results (151-160 of 378) with videos related to

Sort By:
Pageof 38
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 7, 2006
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Rebecca Torguson, et al.
The American Journal of Cardiology|July 15, 2011
Relation of body mass index to on-treatment (clopidogrel + aspirin) platelet reactivityMichael A Gaglia, Rebecca Torguson, Rajbabu Pakala, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|January 22, 2013
The state of the excimer laser for coronary intervention in the drug-eluting stent eraSalem Badr, Itsik Ben-Dor, Danny Dvir, et al.
The American Journal of Cardiology|February 19, 2013
Prevalence and effect of myocardial injury after transcatheter aortic valve replacementIsrael M Barbash, Danny Dvir, Itsik Ben-Dor, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 17, 2014
Transfer distance effect on reperfusion: timeline of ST-elevation patients transferred for primary percutaneous coronary interventionSa'ar Minha, Joshua P Loh, Lowell F Satler, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|May 1, 2014
Outcome comparison of African-American and Caucasian patients with severe aortic stenosis subjected to transcatheter aortic valve replacement: a single-center experienceSa'ar Minha, Israel M Barbash, Marco A Magalhaes, et al.
The American Journal of Cardiology|July 6, 2012
Percutaneous coronary intervention with second-generation paclitaxel-eluting stents versus everolimus-eluting stents in United States contemporary practice (REWARDS TLX Trial)Ron Waksman, Magdi Ghali, Randy Goodroe, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 22, 2016
Promus Premier versus Xience V and Taxus Liberte in contemporary United States practice (REWARDS premier registry)Michael A Gaglia, Randy Goodroe, Greg Mishkel, et al.
The American Journal of Cardiology|December 6, 2006
Comparison of clinical outcomes of overlapping sirolimus- versus paclitaxel-eluting stents in patients undergoing percutaneous coronary interventionWilliam W Chu, Pramod K Kuchulakanti, Rebecca Torguson, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|December 3, 2014
Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trialsMichael J Lipinski, Thibault Lhermusier, Ricardo O Escarcega, et al.
Pageof 38